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The Correlation between Thyrotropin and Dyslipidemia in  
a Population-based Study
This study investigated the relationship between serum thyrotrophin levels and dyslipidemia 
in subclinical hypothyroid and euthyroid subjects. A total of 110 subjects with subclinical 
hypothyroidism and 1,240 euthyroid subjects enrolled in this study. Patients with 
subclinical hypothyroidism had significantly lower high density lipoprotein cholesterol 
(HDL-C) levels than those who were euthyroid. The lipid profiles were each categorized and 
mean thyrotrophin levels were higher in subjects in the dyslipidemia subclasses than 
subjects in the normal subclasses. Thyrotrophin was positively associated with serum 
triglyceride and negatively associated with serum HDL-C in women. Thyrotrophin was also 
positively associated with total cholesterol (TC) in the overweight population along with TC 
and LDL-C in overweight women. In the euthyroid population, thyrotrophin was positively 
associated with TC in the overweight population. In conclusion, serum thyrotrophin was 
correlated with dyslipidemia in subclinical hypothyroid and euthyroid subjects; the 
correlation was independent of insulin sensitivity.
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INTRODUCTION
Many thyroid diseases are significantly correlated with athero-
sclerotic cardiovascular disease (1). The thyroid hormone’s reg-
ulation of lipid metabolism may represent a cause of coronary 
heart disease. Dyslipidemia in hypothyroidism is associated 
with an increased risk for cardiovascular disease (CVD); in some 
cases, subclinical hypothyroidism (SCH), characterized by nor-
mal free thyroxin (FT4) and elevated thyrotrophin (TSH) (2-4). 
Most cardiovascular events occur in subjects with normal thy-
roid function and the question of whether an association of TSH 
with cardiovascular disease exists in the euthyroid range is also 
important. The known associations of overt and subclinical hy-
pothyroidism with hyperlipidemia and dyslipidemia may be 
extended into the normal range of thyroid function. The associ-
ation of high normal TSH levels with the many cardiovascular 
risk factors that cluster within the insulin resistance syndrome 
(5-7) may be an explanation. Evidence from two studies sug-
gests that TSH within the reference range may be positively as-
sociated with total serum cholesterol (8) and low-density lipo-
protein cholesterol (LDL-C) (9), and be negatively associated 
with high-density lipoprotein cholesterol (HDL-C) (9). It was 
shown that total cholesterol (TC) and LDL-C were reduced after 
thyroxine treatment in individuals with TSH in the upper refer-
ence range (10). It was also demonstrated in euthyroid adults 
that the correlation between serum TSH and lipids appears to 
be influenced by insulin resistance (9). Therefore, those with an 
elevated amount of serum TSH and an insulin resistance are at 
a greater risk for dyslipidemia (11). The relationship between 
TSH and lipids remains controversial in subclinical hypothy-Lu L, et al.  •  Correlation between Thyrotropin and Dyslipidemia 
244   http://jkms.org DOI: 10.3346/jkms.2011.26.2.243
roid and euthyroid subjects. We investigated whether there is a 
significant relationship between the levels of TSH and serum 
lipids; we also investigated whether the relationship may be in-
fluenced by insulin resistance or body mass index in a general 
population. Furthermore, we investigated the relationship of 
TSH and lipids in the overweight and normal weight popula-
tion as well as in men and women (which was different from 
previous studies).
 
MATERIALS AND METHODS
Study subjects
Epidemiological studies on diabetes and thyroid disease were 
performed by the Institute of Endocrinology of China Medical 
University in Dadong community, Shenyang City, in 2007 (12). 
The database used for this study consisted of a random sample 
of 1,534 people between the ages of 18 and 85 yr, whose age brack-
ets of 18-29, 30-39, 40-49, 50-59, 60-69, and 70-85 yr made up, 
15.1%, 23.6%, 26.0%, 19.9%, 11.1%, and 4.4% of the total popu-
lation in the community respectively.
  Subjects with a history of a previous thyroid disorder, or who 
took thyroid hormones or antithyroid drugs, were excluded to 
avoid the effects of the drug. In addition, the following subjects 
were excluded: 1) subjects taking medication affecting thyroid 
function (oral contraceptives, estrogen, and glucocorticoid or 
anti-epileptic drugs), 2) subjects with known dyslipidemia and 
taking lipid-lowering medicine, 3) subjects with hyperthyroid-
ism or hypothyroidism, and 4) subjects treated with insulin (to 
ensure the accurate homeostasis model assessment index for 
insulin resistance [HOMA-IR]). Subjects with unavailable per-
sonal data or those who known to have other kinds of diseases 
such as euthyroid sick syndrome and subacute thyroiditis were 
also excluded from this study. Finally, 1,350 subjects were in-
cluded, of which 110 subjects were SCH and 1,240 were euthy-
roid. A total of 847 subjects (62.7%) was female. 
Methods
The participants were asked to complete a questionnaire that 
included demographic data, smoking and alcohol history. They 
were asked if they ever had thyroid disease, diabetes mellitus, 
hypertension, dyslipidemia, or obesity. Information on treat-
ment and family medical history was also collected. The survey 
was conducted between 7 a.m. and 12 p.m.. Body weight, height, 
waist, and hip circumference were measured. The body mass 
index (BMI, kg/m
2) and waist to hip ratio (WHR) were calculat-
ed. Blood samples were obtained from the cubital vein after over-
night fasting. After the centrifugation of blood for 30 min, the 
plasma aliquots were used to assay TC, triglyceride (TG), HDL-
C, and blood glucose (BG) within 6 hr or were transported to 
the laboratory and kept at -70°C until assayed for thyroid func-
tion and insulin.
  Serum TSH and free thyroxine (FT4) were assessed using a 
chemiluminescent immunoassay (IMMULITE1000 Autoana-
lyzer, DPC, USA). Serum lipids were analyzed with an Olympus 
Au400 Autoanalyzer (Olympus, Tokyo, Japan), applying reagents 
from the No. 1 Pharmaceutical Factory of Japan. TC was mea-
sured with a cholesterol oxidase method and the TG was mea-
sured with a glycerophosphate oxidase method. HDL-C was 
analyzed with a selective screening method. LDL-C was calcu-
lated using the Friedewald formula: LDL-C= TC–HDL-C–TG/ 
2.2 (mM/L). Plasma glucose was measured with a hexokinase 
endpoint method. Plasma insulin concentrations were mea-
sured with an immunoradiometric assay (Research Institute of 
North Biotechnology, Beijing, China). The homeostasis model 
assessment (HOMA) index for insulin resistance (HOMA-IR) 
was calculated as fasting insulin (mIU/L) times fasting blood 
glucose (mM/L, FBG) divided by 22.5.
  The normal reference range of TSH is 0.3-4.8 mIU/L. FT4 (nor-
mal reference range, 10.3-24.5 pM/L) and FT3 (normal reference 
range, 2.3-6.3 pM/L) were measured when TSH was not in the 
normal reference range. Diagnostic Criteria: hyperthyroidism 
was TSH < 0.3 mIU/L, FT3 > 6.3 and/or FT4 > 24.5 pM/L. The 
criteria of subclinical hyperthyroidism was TSH < 0.3 mIU/L, 
FT3 and FT4 within the reference range. The criteria of hypothy-
roidism was TSH > 4.8 mIU/L, and FT4 < 10.3 pM/L. The criteria 
of SCH was TSH > 4.8 mIU/L, and FT4 within the reference range. 
Euthyroidism was defined when TSH was 0.3-4.8 mIU/L and 
FT4 was 10.3-24.5 pM/L.
Statistical analyses
SPSS 15.0 (SPSS, Inc., Chicago, IL, USA) and Excel (Microsoft 
Corp., Redmond, WA, USA) were used for data analysis. Data 
was expressed as mean ± SD for data with a normal distribution. 
Statistical comparisons were performed by means of indepen-
dent-samples t tests or analysis of covariance to be adjusted by 
age, sex, and other influential factors. Pearson’s correlation anal-
ysis and multiple linear regression models were performed for 
associations of thyroid function with serum lipid concentrations, 
glucose, and HOMA-IR. TG, TSH, and HOMA-IR values were 
logarithmically transformed for statistical analyses. P < 0.05 was 
considered statistically significant.
Ethics statement
The institutional review board approved this study (IRB approv-
al number: [2007] 29). All participants gave written informed 
consent.
RESULTS 
Comparison of lipid profiles of the SCH and euthyroid 
population
The baseline characteristics of 1,350 participants are shown in Lu L, et al.  •  Correlation between Thyrotropin and Dyslipidemia 
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Table 1. Women with SCH had significantly lower HDL-C than 
those who were euthyroid. The differences remained signifi-
cant after adjustment for age, sex, and BMI (Table 2). However, 
the HDL-C was not different between SCH and euthyroid men. 
Mean levels of TC, TG, and LDL-C were not different in both fe-
male and male subjects with SCH and euthyroid. Table 3 shows 
the comparison of TC, TG, HDL-C, and LDL-C levels according 
to categories of TSH within the reference range. In either men or 
women, there were no significant differences among the groups 
after adjustment for age, sex, and BMI.
Comparison of TSH by lipid profiles categories in the 
whole and euthyroid population
In the whole population, TC, TG, and LDL-C subclasses were 
each categorized as normal, high normal, and high according 
to the treatment guidelines of dyslipidemia for adults in China 
in 2007; and HDL-C subclasses were categorized as low, nor-
mal, and high. The mean TSH levels were higher in subjects in 
the dyslipidemia group than subjects in the normal group (re-
sults not shown). The differences were significant in high LDL-
C subclasses in overweight (BMI 24.0 kg/m
2 or higher accord-
ing to the treatment guidelines of overweight and obesity for 
adults in China) individuals after adjustment for age, sex, and 
BMI (Fig. 1). 
  The mean TSH levels were significantly higher in high TC 
(3.76 ± 2.17 mIU/L vs 2.84 ± 2.45 mIU/L, P = 0.010) and high 
LDL-C (3.76 ± 2.23 mIU/L vs 2.80 ± 2.42 mIU/L, P = 0.022) sub-
classes in overweight women. There were no significant differ-
ences in men or overweight men (results not shown). 
  In 1,240 subjects with normal TSH levels (0.3-4.8 mIU/L), the 
mean TSH levels were significantly greater in high TC (2.40 ± 
0.96 mIU/L vs 2.21 ± 1.10 mIU/L, P = 0.016) and in high LDL-C 
Table 1. Baseline characteristics of participants
Men Women
All SCH Euthyroidism All SCH Euthyroidism
Number 503 21 482 847 89  758
Age    42.66 ± 14.48﹡   44.48 ± 12.74    42.59 ± 14.56﹡   45.37 ± 12.95   46.73 ± 12.48     45.21 ± 13.01
BMI  24.92 ± 3.73﹡ 24.26 ± 3.31  24.95 ± 3.74﹡ 23.70 ± 3.48 24.35 ± 3.13 23.628 ± 3.52
WHR    0.88 ± 0.07﹡    0.88 ± 0.07﹡    0.88 ± 0.07﹡   0.81 ± 0.06   0.83 ± 0.06     0.81 ± 0.06
BG   5.37 ± 1.68   5.01 ± 0.60   5.39 ± 1.71   5.34 ± 1.40   5.43 ± 1.46     5.33 ± 1.39
INS 11.10 ± 6.83 10.68 ± 4.71 11.12 ± 6.91   12.06 ± 28.51 10.45 ± 5.12     12.25 ± 30.09
HOMA-IR   2.70 ± 2.07   2.41 ± 1.16   2.72 ± 2.10   2.87 ± 6.22   2.48 ± 1.21       2.91 ± 6.560
TSH    1.95 ± 1.34﹡   6.37 ± 1.60  1.756 ± 0.94﹡   2.67 ± 2.85     7.84 ± 6.121     2.06 ± 1.06
SCH, TSH > 4.8 mIU/L, FT4 within the reference range. Euthyroidism, TSH 0.3-4.8 mIU/L, FT4 10.3-24.5 pM/L. ﹡Compared with women in the same group P < 0.01. SCH, 
subclinical hypothyroidism; BMI, body mass index; WHR, waist to hip ratio; BG, blood glucose; INS, insulin; HOMA-IR, homeostasis model assessment index for insulin resistance; 
TSH, thyrotrophin.
Table 2. Comparison of lipid profiles between SCH and euthyroid population after adjustment for age, sex, and BMI
Men Women
SCH  
(n = 21)
Euthyroidism  
(n = 482)
P
SCH  
(n = 89)
Euthyroidism  
(n = 758)
P
TC (mM/L) 4.58 ± 0.70 4.75 ± 0.91 0.419 4.86 ± 1.02 4.77 ± 0.97 0.692
TG (mM/L) 1.77 ± 0.89 1.77 ± 1.49 0.211 1.39 ± 1.04 1.24 ± 0.93 0.161
HDL-C (mM/L) 1.13 ± 0.23 1.22 ± 0.30 0.071 1.32 ± 0.30 1.42 ± 0.40 0.035
LDL-C (mM/L) 2.93 ± 0.66 2.96 ± 0.81 0.970 2.98 ± 0.80 2.94 ± 0.87 0.946
TG and TSH values were logarithmically transformed for statistical analyses. SCH, TSH > 4.8 mIU/L and FT4 within the reference range. Euthyroidism, TSH 0.3-4.8 mIU/L, FT4, 
10.3-24.5 pM/L. SCH, subclinical hypothyroidism; TC, total cholesterol; TG, triglyceride; HDL-C, high density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.
Table 3. Comparison of lipid profiles according to categories of TSH within the reference range (FT4, 10.3-24.5 pM/L) after adjustment for age, sex, and BMI
TSH (mIU/L) No. TC (mM/L) TG (mM/L) HDL-C (mM/L) LDL-C (mM/L)
Men 0.3-0.99
1.0-1.89
1.9-4.80
P
105
202
175 
4.67 ± 0.91
4.74 ± 0.91
4.81 ± 0.91
0.427
1.72 ± 1.54
1.83 ± 1.67
1.72 ± 1.23
0.289
1.19 ± 0.30
1.24 ± 0.31
1.22 ± 0.29
0.625
2.95 ± 0.80
2.90 ± 0.79
3.03 ± 0.84
0.547
Women 0.3-0.99
1.0-1.89
1.9-4.80
P
128
265
365
4.76 ± 1.00
4.78 ± 0.94
4.74 ± 0.99
0.800
1.14 ± 0.77
1.23 ± 0.88
1.28 ± 1.00
0.345
1.45 ± 0.50
1.41 ± 0.32
1.41 ± 0.40
0.659
3.01 ± 0.91
2.91 ± 1.86
2.94 ± 0.86
0.711
TG and TSH values were logarithmically transformed for statistical analyses. TSH, thyrotrophin; BMI, body mass index; TC, total cholesterol; TG, triglyceride; HDL-C, high density 
lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.Lu L, et al.  •  Correlation between Thyrotropin and Dyslipidemia 
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(2.44 ± 0.95 mIU/L vs 2.17 ± 1.10 mIU/L, P = 0.035) subclasses 
in overweight women. 
Correlation analysis between TSH and lipid profiles in the 
whole and euthyroid population
There were significant correlations of lipid profiles with age, gen-
der, BMI and WHR in all euthyroid and SCH subjects when an-
alysed by Pearson’s correlation analysis. The TSH was associat-
ed positively with serum TG and negatively with serum HDL-C 
in women (Table 4). There were no significant correlations of 
TSH with TC, TG, HDL-C, and LDL-C in men. 
  Multiple linear regression models were used to determine 
associations of TSH with TC, TG, HDL-C, and LDL-C and to de-
termine whether the associations were either dependent on or 
modified by HOMA-IR values. In the whole population, TSH was 
significantly and positively associated with TG, independently 
of the HOMA-IR value (Table 5) and was not associated with 
HDL-C after adjustment for age, sex, and BMI. In the overweight 
population, TSH was positively associated with TC (r = 0.078, P = 
0.044). And the associations remained significant (β = 0.080, P = 
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≥ 2.26 mM/L (≥ 200 mg/dL)
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Fig. 1. Comparison of TSH by lipid profile categories after adjustment for age and sex in the overweight population. TG and TSH values were logarithmically transformed for 
statistical analyses. The ﹡P = 0.027 was compared to normal LDL-C subclasses. TC, TG, and LDL-C subclasses were each categorized as normal, high normal, and high 
according to the treatment guidelines of dyslipidemia for adults in China in 2007; HDL-C subclasses were categorized as low, normal, and high.
Table 4. Pearso n correlation analysis for lipid profiles in women 
TC TG HDL-C LDL-C
r P r P r P r P
Age 0.394 0.000 0.278 0.000 0.011 0.746 0.271 0.000
BMI 0.169 0.000 0.338 0.000 -0.211 0.000 0.183 0.000
WHR 0.176 0.000 0.367 0.000 -0.143 0.000 0.147 0.000
FBG 0.153 0.000 0.198 0.000 -0.069 0.045 0.105 0.002
Insulin -0.041 0.230 0.017 0.623 -0.011 0.739 -0.030 0.378
HOMA-IR 0.025 0.464 0.249 0.000 -0.154 0.000 0.072 0.037
TSH 0.024 0.490 0.083 0.015 -0.072 0.036 0.006 0.864
TG, TSH, and HOMA-IR values were logarithmically transformed for statistical analyses. TC, total cholesterol; TG, triglyceride; HDL-C, high density lipoprotein cholesterol; LDL-C, 
low-density lipoprotein cholesterol; BMI, body mass index; WHR, waist to hip ratio; FBG, fasting blood glucose; HOMA-IR, homeostasis model assessment index for insulin 
resistance; TSH, thyrotrophin.Lu L, et al.  •  Correlation between Thyrotropin and Dyslipidemia 
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0.039) even after adjustment for age, sex, and BMI independent 
of HOMA-IR value. TSH was positively associated with TC (β = 
0.118, P = 0.017) and LDL-C (β = 0.118, P = 0.021) after adjust-
ment for age, sex, and BMI in overweight women; in addition, it 
was not associated with TC, TG, HDL-C, and LDL-C in normal 
weight women, overweight and normal weight men.
  In all of the euthyroid population, there were no significant 
correlations between TSH and serum TC, TG, HDL-C, and LDL-
C. However, TSH was positively associated with TC after adjust-
ment for age, sex, and BMI in the overweight population (β = 
0.079, P = 0.050) or in overweight women (β = 0.117, P = 0.031) 
and the associations were not modified by the HOMA-IR values 
(results not shown). At the same time, TSH was not associated 
with TC, TG, HDL-C, and LDL-C in normal weight women and 
overweight and normal weight men.
DISCUSSION 
The level of lipid profiles is influenced by many factors. Present 
research has shown that thyroid hormones change the lipid pro-
files. Thyroid hormones may stimulate hydroxymethylglutaryl 
coenzyme A (HMG CoA), the key enzyme of cholesterol biosyn-
thesis, and induce an increased synthesis of cholesterol. Addi-
tionally, the LDL-C receptor gene contains a thyroid hormone 
responsive element (TRE) that could allow triiodothyronine (T3) 
to modulate the gene expression of the LDL-C receptor and result 
in an increase of LDL-C receptor synthesis (13, 14). Patients with 
hypothyroidism had higher baseline serum levels of TC, TG, and 
LDL-C and lower baseline serum levels of HDL-C. Thyroid hor-
mones and their function are low in target tissue in SCH, and 
researchers conjectured that SCH influences lipid profiles by 
the above-mentioned mechanism. 
  Althaus et al. (15) reported that in subjects with SCH LDL-C 
levels were significant increased and HDL-C levels were decreas-
ed when compared to euthyroid subjects, after adjustment for 
age, sex, and BMI. The report (15) provided a possible explana-
tion for the higher prevalence of coronary heart disease report-
ed in SCH. The Colorado thyroid disease prevalence study (16) 
showed that TC and LDL-C in SCH were significantly higher 
than in euthyroidism; but TG and HDL-C were not significantly 
different. This finding was consistent with that of the studies by 
Efstathiadou et al. (17) in which patients with SCH had signifi-
cantly higher levels of TC and LDL-C compared with controls, 
whereas levels of TG and HDL-C were similar in the two groups. 
Another study (18), however, showed that HDL-C and TG levels 
were similar between SCH patients and control groups. Although 
TC and LDL-C levels were higher in patients with SCH than in 
controls, the difference were not statistically significant. In this 
cross-sectional study of 1,350 subjects, serum concentrations of 
HDL-C in SCH are significantly lower than in euthyroidism; in 
addition, TC, TG and LDL-C were not different between the two 
groups after adjustment for age, sex and BMI, which was not 
completely consistent with previous studies.
  Several factors may affect the results of the present study in-
cluding age, sex, BMI, HOMA-IR, and the numbers of subjects. 
The numbers of previous studies were small except for the Col-
orado Thyroid Disease Prevalence Study. In addition, we re-
moved the effects of age, sex, and BMI. We found that the rela-
tionship of TSH and lipids level were different in the overweight 
and normal weight populations, along with those in men and 
women. 
  The present data provides evidence that serum TSH has ef-
fects on serum lipid parameters in the whole population. TSH 
was associated positively with serum TG and negatively with 
serum HDL-C in women. In the whole population, TSH remained 
significantly and positively associated with TG after adjustment 
for age, sex, and BMI, independent of the HOMA-IR value. TSH 
was positively associated with TC in the overweight population 
and positively associated with TC and LDL-C in overweight 
women. The combination of serum TSH, sex, and BMI has im-
portant effects on serum lipid parameters.
  This was suitable to the euthyroid population, that is, TSH 
level was associated with abnormality of TC and LDL-C in over-
weight women. In this study of 1,240 subjects with normal TSH 
Table 5. Multivariate linear regression models for lipid profiles in whole population
Model
TC TG HDL LDL
β P
Adjusted  
r
2 β P
Adjusted  
r
2 β P
Adjusted  
r
2 β P
Adjusted  
r
2
1 TSH 0.03 0.23 0.113 0.05 0.02 0.17 -0.03 0.14 0.112 0.01 0.57 0.05
2 HOMA-I 1 9 0.114 6 6 7 8 8 0.12 5 1 7
3 R 0.05 0.05 0.115 0.23 0.00 0.22 -0.11 0.00 3 0.06 0.02 0.06
TSH 2 3 1 0 4 5 0 0.12 2 6 0
HOMA-I 0.03 0.24 0.05 0.02 0.22 -0.03 0.15 3 0.01 0.58 0.06
R 0 3 5 6 6 7 4 5 1 0
0.05 0.05 0.23 0.00 -0.11 0.00 0.06 0.02
2 4 1 0 5 0 1 6
Models 1 and 2 are simple regressions for TSH and HOMA-IR alone. Model 3 is multiple regression including TSH and HOMA-IR. All models are adjusted for age, sex, BMI and 
WHR. TG, TSH and HOMA-IR values were logarithmically transformed for statistical analyses.Lu L, et al.  •  Correlation between Thyrotropin and Dyslipidemia 
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levels (0.3-4.8 mIU/L), the mean TSH levels were significantly 
higher in high TC and high LDL-C subclasses in overweight 
women. TSH was positively associated with TC after adjustment 
for age, sex, and BMI in the overweight population or in over-
weight women and the associations were not modified by the 
HOMA-IR values. A health adult study (n = 47) (19) found that 
there were significant positive associations of TSH with LDL-C 
and TC with an inverse association with HDL-C independent of 
insulin sensitivity that was assessed with the hyperinsulinemic 
euglycemic clamp technique. In 117 diabetic women (11), the 
correlation between serum TSH and lipids appears to be influ-
enced by insulin resistance; therefore, those with an elevated 
amount of serum TSH and an insulin resistance are at a greater 
risk for dyslipidemia. In 1,581 euthyroid adults, Roos et al. (19) 
demonstrated an association between serum TSH and TG. How-
ever, there was no relationship with other components of lipids 
after adjustment for age, sex, and insulin resistance. In euthy-
roidism (20), subjects with a TSH in the upper normal range 
(2.5 to 4.5 mIU/L) were more obese, had higher TG, and had an 
increased likeliness for metabolic syndrome. Therefore, a TSH 
< 2.5 mIU/L is associated with a favorable metabolic profile. 
Another study (21) showed an association between TSH and 
some components specific of the metabolic syndrome in eu-
thyroid women. In this study, we could not find that the associ-
ation of TSH with TC, TG, HDL-C, and LDL-C were influenced 
by insulin resistance. The conflicting conclusions maybe due to 
the influencing factors of age, sex, BMI, HOMA-IR, and the num-
bers of subjects.
  In conclusion, serum TSH is correlated with dyslipidemia in 
subclinical hypothyroid and euthyroid subjects and the corre-
lation was independent of insulin sensitivity.
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We investigated the relationship between serum thyrotrophin and dyslipidemia in subclinical hypothyroid and euthyroid subjects. 
110 subjects with subclinical hypothyroidism and 1,240 euthyroid subjects were enrolled in the study. Patients with subclinical 
hypothyroidism had significantly lower HDL-C levels than the euthyroid. The mean thyrotrophin levels were higher in subjects in 
the dyslipidemia subclasses than those with normal lipid profile. Thyrotrophin was positively associated with serum TG and 
negatively associated with serum HDL-C in women. Thyrotrophin was also postiviely associated with TC in overweight po pulations 
and with TC and LDL-C in overweight women.  In the euthryoid population, thyrotrophin was positively associated with TC in the 
overweight population. In conclusions, serum thyrotrophin is correlative with dyslipidemia in subclinical hypothyroid and 
euthyroid subjects, and the correlation was independent of insulin sensitivity. 